We checked the regulation of CCNE2 (Cyclin E2) by these miRNAs and its expression in different HER2+ breast cancer cell lines because this gene has been previously implicated in acquired trastuzumab resistance10 and is a possible miR-30b target9. Here, CCNE2 is linked to breast carcinoma.